HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestlé Invests In Microbiome Research As VMS Sales Stumble

Executive Summary

Nestlé announced a partnership with APC Microbiome Ireland for product development as it reported lower vitamin, mineral and supplement sales in the first half of 2023.

You may also be interested in...



Nestlé Health Science Refocuses As It Drops Peanut Allergy Treatment

VMS, active nutrition and medical nutrition will be Nestle Health Science's main focus areas going forward with the business looking to offload peanut allergy treatment Palforzia. The Swiss firm announced the move as it reported organic growth of 4% at Health Science for 2022.

Reckitt Not Worried By Q4 Stumble At 'Jewel' OTC Business

As it felt the effects of a weaker cold & flu season, Reckitt insisted its subdued Q4 showing is not an indicator of how its Health business will perform in 2024. The unit is expected to deliver mid single-digit growth, as it did last year.

EMA Urges Suspension Of Ibuprofen Generic Across Europe

Ibuprofen generic sold by Spain's Liconsa should have its marketing authorization suspended in multiple EU member states as it is not bioequivalent to reference product Nurofen Rapid, rules the European Medicines Agency.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153878

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel